Speaking Faculty

Chris Brodrick, Product Expert, BSI, INC.
Mark Citron, Vice President, Regulatory & Quality, TYRX, INC.
Terry Dagnon, Senior Director, Regulatory Affairs, ALCON LABORATORIES
Eric Edwards, Co-Founder & Chief Scientist, INTELLIJECT
Michael Gross, Senior Consultant, BIOLOGIC CONSULTING GROUP
Rachel Halych, Manager, Global BioTherapeutics Technologies, PFIZER
Robin Hwang, Executive Director, Head of Drug Delivery, HALOZYME THERAPEUTICS, INC.
Frank Isaksson, General Manager, SHL GROUP
Suzanne Kiani, Senior Scientist, CMC
Regulatory Affairs, GENENTECH
John Kinzell, President & CEO, XERIS PHARMACEUTICALS
Lee Leichter, President, P/L BIOMEDICAL
Bradley Merrill Thompson, Shareholder, Health Care and Life Sciences Practice, EPSTEIN, BECKER & GREEN, P.C.
Von Nakayama, Industry Advisor, FORMER FDA REVIEWER AND INSPECTOR
Steven Prestrelski, Vice President, Pharma R&D, AMYLIN
Nancy Reaven, President & Founder, STRATEGIC HEALTH RESOURCES
Asif Sidiqui, Director, Regulatory Affairs, ROCHE MOLECULAR SYSTEMS